Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy - Takeaways - MDSpire

Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy

  • By

  • Ahmad Mourad

  • Adrian F Hernandez

  • October 14, 2025

  • 0 min

Share

  • 1

    Pneumococcal vaccination significantly reduces morbidity and mortality in patients with chronic heart failure.

  • 2

    A targeted mail-in campaign increased vaccination rates from 4% to 35% among heart failure patients in a cluster-randomized trial.

  • 3

    Prior influenza vaccination was the strongest predictor of pneumococcal vaccine uptake in the studied population.

  • 4

    The trial demonstrates the effectiveness of low-cost, scalable public health interventions within existing healthcare systems.

  • 5

    Future research should assess the long-term clinical outcomes of increased pneumococcal vaccination rates in heart failure patients.

Original Source(s)

Increasing pneumococcal vaccination in patients with heart failure: a scalable public health strategy

  • by Ahmad Mourad, Adrian F Hernandez

  • October 14, 2025

Related Content

Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation